Advisors to NCI are preparing to recommend a “Human Cancer Genome Project” that would create a comprehensive chart of the genetic mutations that cause cancer. The panel also plans to propose an initiative in molecular diagnostics, Eric Lander, director of the Broad Institute, said.
Also in this 8-page issue: White House appoints Koch Industries executive David Koch to the National Cancer Advisory Board. He asks: “How can we make the NCI elephant dance like a ballerina?”
Funding opportunities listed.
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted
- The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community
